Capital Investment Advisory Services, LLC Verrica Pharmaceuticals Inc. Transaction History

Capital Investment Advisory Services, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 01, 2022	SELL	$9.1 - $13.36 $137,637 - $202,070	-15,125 Closed	0 $0
Q4 2020 Jan 25, 2021	BUY	$7.41 - $12.63 $112,076 - $191,028	15,125 New	15,125 $174,000
Q3 2020 Oct 19, 2020	SELL	$6.16 - $10.3 $96,250 - $160,937	-15,625 Closed	0 $0
Q1 2020 Apr 28, 2020	BUY	$7.14 - $16.86 $10,710 - $25,290	1,500 Added 10.62%	15,625 $171,000
Q4 2019 Feb 04, 2020	BUY	$13.08 - $17.43 $22,563 - $30,066	1,725 Added 13.91%	14,125 $224,000
Q4 2018 Feb 04, 2019	BUY	$6.75 - $16.12 $11,475 - $27,404	1,700 Added 15.89%	12,400 $101,000
Q2 2018 Aug 01, 2018	BUY	$17.5 - $20.34 $187,250 - $217,638	10,700 New	10,700 $211,000

17.4M

6.1K

6.3K

Ticker VRCA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,094,100
Market Cap $327M
Description
Verrica Pharmaceuticals Inc., a dermatology therapeutics company, develops and commercializes treatments for people with skin diseases in the United States. The company's lead product candidate includes VP-102 for the treatment of molluscum contagiosum; that has completed Phase II clinical trial for the treatment of external genital warts; and w...

Get notified when there are updates to the investment portfolio of Capital Investment Advisory Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Capital Investment Advisory Services, LLC with notifications on news.